HALOZYME THERAPEUTICS, INC. (HALO) Operating margin 2016–2025
HALOZYME THERAPEUTICS, INC. (HALO) operating margin by fiscal year — reported operating income divided by reported revenue.
33.6%FY2025 · since FY2016: -56.7% → 33.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 33.6% | -20.7 pp |
| FY2024 | 54.3% | +13.6 pp |
| FY2023 | 40.7% | +0.2 pp |
| FY2022 | 40.5% | -21.7 pp |
| FY2021 | 62.2% | +8.3 pp |
| FY2020 | 53.9% | +88.4 pp |
| FY2019 | -34.5% | +11.2 pp |
| FY2018 | -45.7% | -71.2 pp |
| FY2017 | 25.6% | +82.3 pp |
| FY2016 | -56.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice